Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TriSalus Life Sciences (TLSIW) Asset Utilization Ratio (2022 - 2025)

TriSalus Life Sciences' Asset Utilization Ratio history spans 4 years, with the latest figure at 1.26 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio rose 9.94% year-over-year to 1.26; the TTM value through Dec 2025 reached 1.26, up 9.94%, while the annual FY2025 figure was 1.52, 25.65% up from the prior year.
  • Asset Utilization Ratio reached 1.26 in Q4 2025 per TLSIW's latest filing, up from 1.03 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 1.26 in Q4 2025 to a low of 0.05 in Q4 2022.
  • Average Asset Utilization Ratio over 4 years is 0.87, with a median of 0.98 recorded in 2024.
  • Peak YoY movement for Asset Utilization Ratio: skyrocketed 1116.94% in 2023, then grew 4.68% in 2025.
  • A 4-year view of Asset Utilization Ratio shows it stood at 0.05 in 2022, then surged by 1116.94% to 0.64 in 2023, then skyrocketed by 79.72% to 1.14 in 2024, then grew by 9.94% to 1.26 in 2025.
  • Per Business Quant, the three most recent readings for TLSIW's Asset Utilization Ratio are 1.26 (Q4 2025), 1.03 (Q3 2025), and 1.03 (Q2 2025).